Alpha Mark Advisors, LLC Atai Life Sciences N.V. Transaction History
Alpha Mark Advisors, LLC
- $284 Million
- Q1 2024
A detailed history of Alpha Mark Advisors, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 200 shares of ATAI stock, worth $256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$256
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
97Shares Held
13.1MCall Options Held
229KPut Options Held
114K-
Morgan Stanley New York, NY2.67MShares$3.41 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.22MShares$2.84 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.4MShares$1.79 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0794KShares$1.02 Million0.0% of portfolio
-
Brown University719KShares$919,6800.61% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $212M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...